Nova Patents
PL2324871T5

Citrate anticoagulation system for extracorporeal blood treatments

Abstract

This record has no abstract on file.

Term

0.2 yearsto projected expiry

Projected expiry 22 November 2026, counted from filing; an application has no term until it is granted.

  1. Priority
  2. Filed
  3. Published
  4. Today
  5. Projected expiry

45 members in 13 offices

This recordMember, by publication datePriority claim3 more offices are in the list below

Priority claims17

Priority claims
DocumentOfficeKindDate
73908605United States of AmericaP
73908605United States of AmericaP
60282706United States of AmericaA
60282706United States of AmericaA
06838361European Patent Office (EPO)A
06838361European Patent Office (EPO)A
11153847European Patent Office (EPO)A
2006045351United States of AmericaW
2006045351United States of AmericaW
111538476–––
602827–––
739086P–––
EP20060838361–––
EP20110153847–––
US20050739086P–––
US20060602827–––
WO2006US45351–––

Members45

Family members, oldest first
DocumentOfficeKind
WO0064456A2World Intellectual Property Organization (WIPO)A2
AU4553700AAustraliaA
WO0064456A3World Intellectual Property Organization (WIPO)A3
EP1176969A2European Patent Office (EPO)A2
US6743191B1United States of AmericaB1
US2004129638A1United States of AmericaA1
US7186420B2United States of AmericaB2
US2007062861A1United States of AmericaA1
CA2630798A1CanadaA1
WO2007062197A1World Intellectual Property Organization (WIPO)A1
US2007134348A1United States of AmericaA1
EP1176969B1European Patent Office (EPO)B1
AT405277TAustriaT
ATE405277T1AustriaT1
DE60039978D1GermanyD1
EP2001532A1European Patent Office (EPO)A1
ES2315228T3SpainT3
JP2009516575AJapanA
US7758900B2United States of AmericaB2
US2010301268A1United States of AmericaA1
EP2324871A2European Patent Office (EPO)A2
US8105258B2United States of AmericaB2
US2012045364A1United States of AmericaA1
US8158157B2United States of AmericaB2
US2012123314A1United States of AmericaA1
US8216172B2United States of AmericaB2
JP5023071B2JapanB2
EP2324871A3European Patent Office (EPO)A3
EP2001532B1European Patent Office (EPO)B1
ES2421616T3SpainT3
US8529486B2United States of AmericaB2
US2013323122A1United States of AmericaA1
CA2630798CCanadaC
US8795517B2United States of AmericaB2
EP2324871B1European Patent Office (EPO)B1
PT2324871TPortugalT
DK2324871T3DenmarkT3
SI2324871T1SloveniaT1
ES2592955T3SpainT3
PL2324871T3PolandT3
EP2324871B2European Patent Office (EPO)B2
DK2324871T4DenmarkT4
PL2324871T5This recordPolandT5
SI2324871T2SloveniaT2
ES2592955T5SpainT5